Detalles de la búsqueda
1.
Swiss QUality of life and healthcare impact Assessment in a Real-world Erenumab treated migraine population (SQUARE study): interim results.
J Headache Pain
; 23(1): 142, 2022 Nov 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-36401172
2.
Impact on monthly migraine days of discontinuing anti-CGRP antibodies after one year of treatment - a real-life cohort study.
Cephalalgia
; 41(11-12): 1181-1186, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34000847
3.
Pharmaceutically treated comorbidities and associated healthcare costs among triptan users in Switzerland: A pharmacoepidemiological study from a nationwide health insurance database.
Pharmacoepidemiol Drug Saf
; 29(3): 279-287, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31828875
4.
Migraine Burden of Disease: From the Patient's Experience to a Socio-Economic View.
Headache
; 58 Suppl 1: 17-32, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29697152
5.
Correction: Swiss QUality of life and healthcare impact Assessment in a Real-world Erenumab treated migraine population (SQUARE study): interim results.
J Headache Pain
; 23(1): 161, 2022 Dec 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-36536271
6.
Implications of therapy interruption on monthly migraine days and modified migraine disability assessment in patients treated with erenumab for chronic and episodic migraine: SQUARE study interim results.
J Neurol
; 2024 Jun 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-38871822
7.
Desogestrel-only contraception may reduce headache frequency and improve quality of life in women suffering from migraine.
Eur J Contracept Reprod Health Care
; 18(5): 394-400, 2013 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-23927694
8.
Self-reported headache among the employees of a Swiss university hospital: prevalence, disability, current treatment, and economic impact.
J Headache Pain
; 14: 29, 2013 Mar 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-23565579
9.
Prevalence and Burden of Migraine in Switzerland: Cross-Sectional Study in ten Specialised Headache Centres from the BECOME Study.
Pain Ther
; 12(2): 575-591, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-36842093
10.
Spontaneous acute spinal subdural hematoma: spontaneous recovery from severe paraparesis--case report and review.
Acta Neurochir (Wien)
; 152(11): 1981-4, 2010 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-20700748
11.
Treatment patterns in patients using triptan and prophylactic medication: an analysis of clinical practice prior to the introduction of CGRP antagonists.
J Pain Res
; 12: 2211-2221, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31413619
12.
Cessation versus continuation of 6-month migraine preventive therapy with topiramate (PROMPT): a randomised, double-blind, placebo-controlled trial.
Lancet Neurol
; 6(12): 1054-62, 2007 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-17988947
13.
Two replicate randomized, double-blind, placebo-controlled trials of the time to onset of pain relief in the acute treatment of migraine with a fast-disintegrating/rapid-release formulation of sumatriptan tablets.
Clin Ther
; 27(4): 407-17, 2005 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-15922814
14.
Guidelines for the organization of headache education in Europe: the headache school.
Funct Neurol
; 20(2): 89-93, 2005.
Artículo
en Inglés
| MEDLINE | ID: mdl-15966273
15.
Patients profiling for Botox® (onabotulinum toxin A) treatment for migraine: a look at white matter lesions in the MRI as a potential marker.
Springerplus
; 2: 377, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-24010035
16.
5HT1F- and 5HT7-receptor agonists for the treatment of migraines.
CNS Neurol Disord Drug Targets
; 6(4): 235-7, 2007 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-17691977
17.
Nosology and treatment of primary headache in a Swiss headache clinic.
J Headache Pain
; 6(3): 121-7, 2005 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-16355292
18.
Genetics of migraine: possible links to neurophysiological abnormalities.
Headache
; 42(5): 365-77, 2002 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-12047339
Resultados
1 -
18
de 18
1
Próxima >
>>